Event
This International Myeloma Foundation Regional Community Workshop is a virtual workshop, set in an engaging environment that offers myeloma patients and caregivers up-to-the- minute information about multiple myeloma. Topics include an introduction to myeloma (Myeloma 101…
Videos
(click on the image above to view the video)Virtual Myeloma Webinar For Patients and Caregivers Multiple Myeloma Experts Present the Latest Information on Myeloma in 2021, Discuss How Patients Can Stay Safe From the Emerging COVID-19 Variants, and the Importance of the COVID-19…
Event
My mother, Josephine Speller, was diagnosed with multiple myeloma on September 23, 2019 and on November 7, 2019 she transitioned. This was her second battle with MM, and unfortunately, she did not win this battle. My mom loved jewelry, beautiful jewelry, and she introduced me to the love of jewelry…
Event
Register now for a free, interactive online workshop, Saturday, March 20, to learn about multiple myeloma, a disease more than twice as common in people of African descent as in whites. From “Myeloma for Patients Who Are Just Getting Started” to the latest in treatments and research, this…
News Article
Los Angeles, CA, March 11, 2021 –The International Myeloma Foundation (IMF) today launched a multiyear, multidisciplinary initiative called “M-Power Charlotte,” designed to empower people to change the course of myeloma by removing barriers to early diagnosis and treatment in the…
News Article
As part of the mission of International Women’s Day, the International Myeloma Foundation celebrates the achievements of women. In particular, the IMF recognizes the achievements of the organization’s President, Founder, and CEO Susie Durie.
Along with her late husband Brian Novis, Susie founded…
Videos
A Virtual Webinar on How Myeloma Patients Can Build Resilience During the COVID-19 Pandemic
A Coaching Approach to Building Personal Resilience.
In this special virtual presentation, IMF Chairman of the Board Dr. Brian G.M. Durie and Dr. Susan Dunnett, a Senior Lecturer at the University of…
News Article
NORTH HOLLYWOOD, CA, February 25, 2021—Spearheaded by the International Myeloma Foundation, Myeloma Action Month takes place every March to encourage individuals and groups to take actions that positively impact the myeloma community. This year the IMF invites you to join the…
Page
The IMF has partnered with myINTERACT to centralise all your go-to resources and news from the IMF, local support groups, and treatment providers. Learn more about the app here so you never miss a thing.
IMF Person
A Los Angeles native, with the IMF for over 5 years. Work in both the Accounting and Distribution departments doing a variety of tasks. Assist with financial analysis, payables, invoices and many other financial operations to ensure all details and activities have been accounted for and allocated…
Event
On Thursday, February 25, 2021, the IMF will host a FREE “Living Well with Myeloma” Webinar on “Building Your Resilience During Challenging Times," Featured speakers are IMF Chairman of the Board Dr. Brian G.M. Durie and Dr. Susan Dunnett, a Senior Lecturer at the University of Edinburgh in…
News Article
The Scandinavian island’s unique combination of genetic homogeneity, genealogical tradition, and high participation in research make it a prime location for discovery and validation of drug targets.
When patients test as having borderline high-risk smoldering myeloma, should they receive treatment?
Videos
Should borderline high-risk smoldering myeloma patients receive treatment?
Dr. Brian G.M. Durie discusses if patients with borderline high-risk smoldering myeloma should start treatment early.
The BOTTOM LINE:
Monitor your myeloma-levels closely. Discuss your options carefully…
Page
The latest updates and information on COVID-19 for myeloma patients: Vaccines, boosters, anti-viral treatments, and answers to FAQs
Event
Dr. Brian G.M. Durie discusses key takeaways from the annual conference and explains how this new and important information relates to myeloma patients, caregivers, and other members of the myeloma community.
…
News Article
The U.S. Food and Drug Administration (FDA) has approved XPOVIO® (selinexor), a first-in-class, oral Selective Inhibitor of Nuclear Export (SINE) medicine, in combination with bortezomib and dexamethasone for the treatment of adult patients with multiple myeloma who have received at least one…
News Article
The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the initiation of a rolling submission of its Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for ciltacabtagene autoleucel (cilta-cel), an investigational B-cell maturation antigen (…
News Article
On December 11, 2020, the National Comprehensive Cancer Network® (NCCN) added three different XPOVIO® (selinexor) combination regimens to its Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for previously treated multiple myeloma. Click here to learn more.
Videos
Should myeloma patients adjust their treatment plan?
Dr. Brian G.M. Durie discusses the options available to myeloma patients who have a low level of myeloma protein detectable, and if this means patients should alter their treatment regimen.
The BOTTOM LINE:
If a low…
Videos
Updates on Cevostamab in Relapsed/Refractory Myeloma From ASH 2020
In this video:
Dr. Adam Cohen talks about the initial clinical activity and safety of cevostamab, a FcRH5/CD3 T-Cell-engaging bispecific antibody, in relapsed/refractory multiple myeloma.
What is the purpose of this study…
Videos
Dr. Nikhil Munshi Discusses Biallelic BCMA Loss at ASH 2020
Results Identify Biallelic Loss of BCMA Locus as a Potential Resistance Mechanism to BCMA-Targeting Therapy
In this video:
Presented at the American Society of Hematology (ASH) meeting in 2020, Dr. Nikhil Munshi …
Videos
Discussing ASH Abstract 290: A Phase 1 Study of Talquetamab
Dr. Ajai Chari presents findings from the phase 1 study of talquetamab for the treatment of relapsed/refractory myeloma at ASH 2020.
What is the purpose of this study?
Talquetamab is a first-in-class, and the only…
Videos
What is the purpose of this study?
The phase 1 study will explore the use of this B-cell maturation antigen (BCMA)–directed CAR T-cell therapy idecabtagene vicleucel (ide-cel; bb2121) in patients with high-risk newly diagnosed multiple myeloma.
In this video:…
Videos
What is the purpose of this study?
Teclistamab is a bispecific antibody that activates T cells to attack multiple myeloma cells expressing BCMA, or B cell maturation antigen. These updated results from the phase I show, for the first time, the safety and efficacy of the more…
Videos
What is the purpose of this study?
To find out the safety and efficacy of iberdomide with dexamethasone and daratumumab (IberDd) or bortezomib and dexamethasone (IberVd).
In this video:
Dr. Neils van de Donk discussed the safety and efficacy of the two…
Videos
What is the purpose of this study?
Melflufen is a first-in-class peptide-drug conjugate that enables alkylating agents to be released directly into tumor cells. The phase 1/2 study OP-104 ANCHOR evaluates the safety and efficacy of melflufen and dexamethasone in a triplet…
Videos
What is the purpose of this study?
The aims of this analysis were to evaluate the progression-free survival (PFS) of KRd induction-ASCT-KRd consolidation (KRd_ASCT) vs 12 cycles of KRd (KRd12) vs KCd induction-ASCT-KCd consolidation (KCd_ASCT) and the PFS of KR vs R maintenance…
Videos
What is the purpose of this study?
Determine the efficacy of Carfilzomib in combination with Dexamethasone and Daratumumab (KdD) versus Daratumumab with Bortezomib and Dexamethasone (DVd)
In this video:
Dr. Katja Weisel presents the analysis…
Videos
What is the purpose of this study?
CARTITUDE-1 consists of a phase Ib/II portion. The primary objective of the phase Ib was to characterize its safety and confirm the recommended phase II dose, as inferred by the LEGEND-2 study, but in a slightly different population. The…
Videos
What is the purpose of this study?
The multicenter, double-blind phase 3 TOURMALINE-MM2 trial (ClinicalTrials.gov Identifier: NCT01850524)…
Videos
In this episode, Dr. Brian G.M. Durie shares how the "Swiss Cheese" model, a model used in healthcare to analyze risk, can help illustrate how myeloma patients can stay safe during the pandemic.
The BOTTOM LINE:
Talk to your doctor about how you can best remain safe. A…
Videos
What is the purpose of this study?
Determine the level of concordance between tumor/immune landscape in bone marrow (BM) vs peripheral blood (PB) of SMM patients. Evaluate immune profiles together with circulating tumor cell (CTC) numbers and genetic alterations every 6 months…
Videos
What is the purpose of this study?
In this analysis, we aimed at confirming the applicability and validity of DS criteria to define PET/CT CMR and showing their impact on patient’s outcomes in the multicenter phase II randomized FORTE trial for Newly Diagnosed Transplant…
Videos
click on the image above to view the video
View Slides
The IMWG Conference Series Outlines Myeloma News and Trends From the…
Videos
What is the purpose of this study?
The aim of the study is to evaluate AMG 701, a BiTE® molecule binding BCMA on MM cells and CD3 on T cells, in RR MM (Amgen, NCT03287908); primary objective was to evaluate safety and tolerability and estimate a biologically active dose;…
Results of Newly Diagnosed Transplant-Eligible Multiple Myeloma Patients Enrolled in the Forte Trial
Videos
What is the purpose of this study?
The aims of this analysis were the evaluation of (1) the rate of conversion from MRD-positivity (MRD-pos) to MRD-negativity (MRD-neg) with MFC and NGS during maintenance and (2) the impact on progression-free survival (PFS) and overall survival…
Videos
What is the purpose of this study?
The randomized, open-label, multicenter, phase 3 CANDOR study compared carfilzomib, dexamethasone, and daratumumab (KdD) to carfilzomib and dexamethasone (Kd) in patients with multiple myeloma who have relapsed after 1–3 prior lines of therapy…
Videos
In 1995, the IMF established the Brian D. Novis Research Grant program in memory of its co-founder. The grants are awarded annually to promote research in all areas of myeloma in an effort to improve patient outcomes. To date, the IMF has funded more than 100 of the most promising projects by both…
Page
We invite you to attend the symposium New Strategies for Multiple Myeloma Care: Case Studies for Nurses. We share patient case studies, the latest drug approvals, and clinical trial updates.
This FREE Symposium was recently launched at the Oncology Nursing Society’s Bridge Virtual…
Videos
click the image above to view the replay
Join us for this live, CME-certified webinar featuring discussion of patient case studies and key clinical trial data by renowned clinical experts providing their perspectives on recent advances in the treatment of multiple myeloma. You will have…
Event
On September 2, 2020, my Dad was diagnosed with multiple myeloma. I had never heard of this before and not only was this news devastating to our family, but we were even more devastated to learn there is no cure. So my family and I have made it our mission to help find a cure for…
Event
The tiny bea began in Seattle in 2012 when I decided it was time to share some of my father's legacy with the world. I started with bolo ties and expanded from there. Many of the agates, jaspers and opals are collector's specimens, so some pieces are priced to reflect that. I am…
Videos
In this episode, Dr. Brian G.M. Durie shares how the recently FDA-approved Darzalex Faspro® can benefit myeloma patients.
The BOTTOM LINE:
Darzalex Faspro is a subcutaneous monoclonal antibody approved to treat myeloma patients in both the frontline and relapse setting…
Page
For more than a decade, the International Myeloma Foundation has attended the American Society of Hematology (ASH) annual meeting, an exciting convergence of more than 30,000 health-care professionals from around the world. Explore this page to learn about the latest blood cancer research from the…
Videos
click on the image above to view the video
Virtual Myeloma Workshop Focusing on Communities in the Great Lakes Region of the United States
What Is Included in This Virtual Myeloma Workshop?
This IMF Virtual…
Videos
click on the image above to view the video
Southwest USA Virtual Myeloma Workshop
What Is Included in This Virtual Myeloma Workshop?
This IMF Virtual Regional Community Workshop brings…
Videos
click on the image above to view the video
How to Prepare for Virtual Telemedicine Appointments
Practical Tips on Staying Connected With Your Healthcare Team Virtually
This year, many patients have the option to use telehealth or telemedicine services as a way…